Epigenetic silencing of DACH1 induces loss of transforming growth factor-<i>β</i>1 antiproliferative response in human hepatocellular carcinoma
Hongbin Zhu(Chinese PLA General Hospital), Mingzhou Guo(Chinese PLA General Hospital), Ling Hu(University of South China), Kunyu Jing(Chinese PLA General Hospital), Jing Yuan(Ministry of Ecology and Environment), Wenji Yan(Chinese PLA General Hospital), Yan Dong(Chinese PLA General Hospital), Kongming Wu(First Affiliated Hospital of Zhengzhou University), Yazhuo Li(Chinese PLA General Hospital), Yunsheng Yang(Chinese PLA General Hospital)
Cited by 67
Related Papers
Combination strategies with PD-1/PD-L1 blockade: current advances and future directions
|Molecular Cancer|2022|1.4k
Development and Validation of the Rome IV Diagnostic Questionnaire for Adults
|Gastroenterology|2016|696
Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy
|Molecular Cancer|2022|458
Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction
|mSystems|2018|322
Chimeric antigen receptor T cells: a novel therapy for solid tumors
|Journal of Hematology & Oncology|2017|306